IGF1 and Miyoshi myopathy: Within the circulation, we found no significant difference in total IGFI levels between MM patients (117.7 ng/ml; CI 104.9–130.5) (n = 17) and control individuals (137.2 ng/ml; CI 123.8–150.6) (n = 15) (Fig 1A).